Our results showed lower rate of positivity of CD200 that may be attributed to inclusion of newly diagnosed patients and exclusion of secondary leukemia which show increased rate of expression of CD200 as discussed by Damiani et al., (2015). This evidence concerns the gene CD200 and leukemia.